Frontiers in Physiology (Oct 2024)

Clinical implication of electrocardiogram change in patients experiencing lung transplantation with end stage lung disease

  • Ah Young Leem,
  • Hee Tae Yu,
  • MinDong Sung,
  • Kyung Soo Chung,
  • Yeonkyeong Kim,
  • Ala Woo,
  • Song Yee Kim,
  • Moo Suk Park,
  • Young Sam Kim,
  • Young Ho Yang,
  • Ha Eun Kim,
  • Jin Gu Lee,
  • Kyuseok Kim,
  • Kyu Bom Kim,
  • Boyoung Joung,
  • Junbeom Park,
  • Junbeom Park,
  • Su Hwan Lee

DOI
https://doi.org/10.3389/fphys.2024.1440307
Journal volume & issue
Vol. 15

Abstract

Read online

IntroductionEnd-stage lung disease causes cardiac remodeling and induces electrocardiogram (ECG) changes. On the other way, whether lung transplantation (LTx) in end-stage lung disease patients are associated with ECG change is unknown. The object of this study was to investigate ECG changes before and after LTx in end-stage lung disease patients and whether these changes had clinical significance.MethodThis was a single-center retrospective cohort study of 280 end-stage lung disease patients who consecutively underwent LTx at a tertiary referral hospital. ECG findings before LTx and within 1 week and 1, 3, and 6 months after LTx were obtained and analyzed. To find clinical meaning, the ECG at 1 month after LTx was analyzed according to 1-year survival (survivor vs non-survivor groups). Survival data were estimated using the Kaplan–Meier method.ResultsSignificant differences were observed in the PR interval, QRS duration, QT interval, QTc interval, and heart rate before LTx and 1 month after LTx; the PR interval, QRS duration, QTc interval, and heart rate were decreased. Particularly, the QTc interval was significantly decreased 1 month after LTx, whereas there was no significant change in the QTc interval from 1 to 6 months thereafter. The PR interval, QT interval, QTc interval, and heart rate were significantly different between the survivor and non-survivor groups. The serial changes in QTc interval before LTx and 1 and 3 months after LTx were also significantly different between the survivor and non-survivor groups (p = 0.040 after adjusting for age and body mass index). Upon dividing the patients based on the range of QTc interval change ≤ -8 ms, >-8–10 ms, >10–35 ms, >35 ms), the survival rate was significantly lower in the group whose QTc interval at 1 month after LTx decreased by > 35 m (p = 0.019).ConclusionLTx in patients with end-stage lung disease may induce ECG changes. Patients whose QTc interval at 1 month after LTx decreased by > 35 ms have a significantly higher 1-year mortality rate. Hence, these ECG changes may have clinical and prognostic significance.

Keywords